Tokyo Tape
Sign in
← Nihon Chouzai

Half-year report · Q2

3341.TEDINET S100URMJ
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥175.6bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥340.3bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥166.3bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥423m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥3.4bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥772m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥9.4bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥762m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥3.4bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥43m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥43m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥204.1bnat 2024-09-30Cons.Assets
Total assets¥195.1bnat 2024-03-31Cons.Assets
Total assets¥193.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥146.3bnat 2024-09-30Cons.Liabilities
Total liabilities¥136.7bnat 2024-03-31Cons.Liabilities
Net assets / equity¥57.9bnat 2024-09-30Cons.Net assets
Net assets / equity¥58.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥57.9bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥26.4bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥26.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥26.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥26.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.2bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥23.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥20.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥6.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥4.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥4.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-1.442024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.352023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.442023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio28.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio29.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥6.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥6.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥4.2bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥156.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥156.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥4.5bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥6.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥122m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥766m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥19.6bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥13.1bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6.5bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥652m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥182.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥175.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥6.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥4.6bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥6.7bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥6.7bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥3.5bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥147.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥147.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥14m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥698m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.8bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥167m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥173.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥166.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥6.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Subsidy income noiPrior1YTDDuration22000000JPY
Subsidy income noiCurrentYTDDuration330000000JPY
Other noiPrior1YTDDuration113000000JPY
Other noiCurrentYTDDuration353000000JPY
Non operating incomePrior1YTDDuration477000000JPY
Non operating incomeCurrentYTDDuration1143000000JPY
Interest expenses noePrior1YTDDuration178000000JPY
Interest expenses noeCurrentYTDDuration212000000JPY
Rent expense noePrior1YTDDuration197000000JPY
Rent expense noeCurrentYTDDuration326000000JPY
Other noePrior1YTDDuration132000000JPY
Other noeCurrentYTDDuration254000000JPY
Non operating expensesPrior1YTDDuration508000000JPY
Non operating expensesCurrentYTDDuration793000000JPY
Ordinary incomePrior1YTDDuration3367000000JPY
Ordinary incomeCurrentYTDDuration772000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration51000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration11000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration14000000JPY
Compensation income eiPrior1YTDDuration32000000JPY
Compensation income eiCurrentYTDDuration33000000JPY
Extraordinary incomePrior1YTDDuration84000000JPY
Extraordinary incomeCurrentYTDDuration58000000JPY
Impairment loss elPrior1YTDDuration71000000JPY
Impairment loss elCurrentYTDDuration69000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales of noncurrent assets elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration72000000JPY
Extraordinary lossCurrentYTDDuration69000000JPY
Income before income taxesPrior1YTDDuration3378000000JPY
Income before income taxesCurrentYTDDuration762000000JPY
Income taxes currentPrior1YTDDuration1702000000JPY
Income taxes currentCurrentYTDDuration405000000JPY
Income taxes deferredPrior1YTDDuration-71000000JPY
Income taxes deferredCurrentYTDDuration399000000JPY
Income taxesPrior1YTDDuration1630000000JPY
Income taxesCurrentYTDDuration805000000JPY
Profit lossPrior1YTDDuration1748000000JPY
Profit lossCurrentYTDDuration-43000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1748000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-43000000JPY
Profit lossPrior1YTDDuration1748000000JPY
Profit lossCurrentYTDDuration-43000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration2000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration0JPY
Other comprehensive incomePrior1YTDDuration2000000JPY
Other comprehensive incomeCurrentYTDDuration0JPY
Comprehensive incomePrior1YTDDuration1750000000JPY
Comprehensive incomeCurrentYTDDuration-42000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass